发明名称 |
ENHANCED DRUG DELIVERY IN TRANSDERMAL SYSTEMS |
摘要 |
A composition for transdermal administration resulting from an admixture includes: a therapeutically effective amount of a drug that includes a paren t drug and a prodrug; and a pharmaceutically acceptable carrier, wherein the parent drug and prodrug are individually present in an amount sufficient for a pharmacological effect. In a preferred embodiment, the admixture includes: a therapeutically effective amount of a pharmaceutically active agent that includes a corresponding steroid and a steroid derivative; and a carrier for the pharmaceutically active agent. The steroid and the corresponding steroid derivative are present in a weight ratio of 10:1 to 1:10 steroid: corresponding steroid derivative. In a preferred embodiment ratio is 6:1 to 1:6. In a preferred embodiment, the corresponding steroid derivative is a steroid ester. In another preferred embodiment, the carrier is a polymer tha t includes a pressure-sensitive adhesive. In another preferred embodiment, the parent drug is an ACE inhibitor such as ramipril and the prodrug is an ACE inhibitor prodrug such as ramipril ethyl and/or methyl ester.
|
申请公布号 |
CA2451043(A1) |
申请公布日期 |
2002.12.27 |
申请号 |
CA20022451043 |
申请日期 |
2002.06.18 |
申请人 |
NOVEN PHARMACEUTICALS, INC. |
发明人 |
NGUYEN, VIET;HOUZE, DAVID |
分类号 |
A61K9/00;A61K9/70;A61K31/403;A61K31/56;A61K31/565;A61K31/567;A61K31/5685;A61K31/57;A61K31/573;A61K38/55;A61K45/00;A61K45/06;A61K47/10;A61K47/12;A61K47/32;A61K47/34;A61K47/48;A61P5/26;A61P5/30;A61P9/12;A61P43/00;(IPC1-7):A61K31/56;A61K31/40;A61K31/415;A61K31/55 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|